Rick Fornelli, MD | |
380 E Bayfront Pkwy Ste 3, Erie, PA 16507-2408 | |
(814) 877-9060 | |
(814) 877-9089 |
Full Name | Rick Fornelli |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 29 Years |
Location | 380 E Bayfront Pkwy Ste 3, Erie, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316998263 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD072365L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Upmc Hamot Hospital | Erie, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regional Health Services Inc | 4880593722 | 484 |
News Archive
Researchers in The University of Manchester's School of Medicine are undertaking a pilot study into the healthy bone development of teenage mothers, as part of an ongoing commitment to supporting the health of young families.
One of Chicago's most distinctive new buildings has now been certified as among the greenest. Rush University Medical Center's innovative new hospital building, the Tower, which opened in January, has earned LEED Gold certification from the U.S. Green Building Council and verified by the Green Building Certification Institute. It is the largest new construction healthcare project in the world to be LEED Gold certified.
Nanomedicine refers to field of science that uses nanotechnology for clinical operations. The use of nanoparticles has specially been successful due to their structure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
› Verified 3 days ago
Entity Name | Ear Nose And Throat Specialists Of Northwestern Pennsylvania |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194754846 PECOS PAC ID: 0648184283 Enrollment ID: O20031118000112 |
News Archive
Researchers in The University of Manchester's School of Medicine are undertaking a pilot study into the healthy bone development of teenage mothers, as part of an ongoing commitment to supporting the health of young families.
One of Chicago's most distinctive new buildings has now been certified as among the greenest. Rush University Medical Center's innovative new hospital building, the Tower, which opened in January, has earned LEED Gold certification from the U.S. Green Building Council and verified by the Green Building Certification Institute. It is the largest new construction healthcare project in the world to be LEED Gold certified.
Nanomedicine refers to field of science that uses nanotechnology for clinical operations. The use of nanoparticles has specially been successful due to their structure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
› Verified 3 days ago
Entity Name | Regional Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174520654 PECOS PAC ID: 4880593722 Enrollment ID: O20040108000694 |
News Archive
Researchers in The University of Manchester's School of Medicine are undertaking a pilot study into the healthy bone development of teenage mothers, as part of an ongoing commitment to supporting the health of young families.
One of Chicago's most distinctive new buildings has now been certified as among the greenest. Rush University Medical Center's innovative new hospital building, the Tower, which opened in January, has earned LEED Gold certification from the U.S. Green Building Council and verified by the Green Building Certification Institute. It is the largest new construction healthcare project in the world to be LEED Gold certified.
Nanomedicine refers to field of science that uses nanotechnology for clinical operations. The use of nanoparticles has specially been successful due to their structure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Rick Fornelli, MD 380 E Bayfront Pkwy Ste 3, Erie, PA 16507-2408 Ph: (814) 877-9060 | Rick Fornelli, MD 380 E Bayfront Pkwy Ste 3, Erie, PA 16507-2408 Ph: (814) 877-9060 |
News Archive
Researchers in The University of Manchester's School of Medicine are undertaking a pilot study into the healthy bone development of teenage mothers, as part of an ongoing commitment to supporting the health of young families.
One of Chicago's most distinctive new buildings has now been certified as among the greenest. Rush University Medical Center's innovative new hospital building, the Tower, which opened in January, has earned LEED Gold certification from the U.S. Green Building Council and verified by the Green Building Certification Institute. It is the largest new construction healthcare project in the world to be LEED Gold certified.
Nanomedicine refers to field of science that uses nanotechnology for clinical operations. The use of nanoparticles has specially been successful due to their structure.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
› Verified 3 days ago
Carter Mccance Denne, D.O Otolaryngology Medicare: Medicare Enrolled Practice Location: 380 E Bayfront Pkwy, Erie, PA 16507 Phone: 814-877-9060 Fax: 814-877-9089 | |
Dr. Jack Bryant Anon, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, Erie, PA 16505 Phone: 814-864-9994 Fax: 814-866-2655 | |
Dr. Stephen Eugene Schell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, Erie, PA 16505 Phone: 814-864-9994 Fax: 814-866-2655 | |
Dr. Sean Thomas Carroll, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 380 E Bayfront Pkwy Ste 3, Erie, PA 16507 Phone: 814-877-9060 Fax: 814-877-9089 | |
Robert Guelcher, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 521 Montmarc Blvd, Erie, PA 16504 Phone: 814-825-7954 | |
Dr. Sidney Philip Lipman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, #200, Erie, PA 16505 Phone: 814-864-9994 Fax: 814-866-2655 |